Shockwave Medical Stock Current Asset
SWAVDelisted Stock | USD 268.45 6.44 2.34% |
Shockwave Medical fundamentals help investors to digest information that contributes to Shockwave Medical's financial success or failures. It also enables traders to predict the movement of Shockwave Stock. The fundamental analysis module provides a way to measure Shockwave Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shockwave Medical stock.
Shockwave |
Shockwave Medical Company Current Asset Analysis
Shockwave Medical's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, Shockwave Medical has a Current Asset of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Shockwave Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shockwave Medical's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Shockwave Medical could also be used in its relative valuation, which is a method of valuing Shockwave Medical by comparing valuation metrics of similar companies.Shockwave Medical is currently under evaluation in current asset category among its peers.
Shockwave Fundamentals
Return On Equity | 0.25 | |||
Return On Asset | 0.0868 | |||
Profit Margin | 0.21 % | |||
Operating Margin | 0.19 % | |||
Current Valuation | 12.32 B | |||
Shares Outstanding | 37.54 M | |||
Shares Owned By Insiders | 1.19 % | |||
Shares Owned By Institutions | 98.72 % | |||
Number Of Shares Shorted | 1.83 M | |||
Price To Earning | 178.55 X | |||
Price To Book | 18.38 X | |||
Price To Sales | 16.83 X | |||
Revenue | 730.23 M | |||
Gross Profit | 424.74 M | |||
EBITDA | 176.35 M | |||
Net Income | 147.28 M | |||
Cash And Equivalents | 224.91 M | |||
Cash Per Share | 6.26 X | |||
Total Debt | 770.61 M | |||
Debt To Equity | 0.15 % | |||
Current Ratio | 5.32 X | |||
Book Value Per Share | 20.04 X | |||
Cash Flow From Operations | 196.05 M | |||
Short Ratio | 2.24 X | |||
Earnings Per Share | 4.25 X | |||
Price To Earnings To Growth | 1.38 X | |||
Target Price | 324.27 | |||
Number Of Employees | 1.47 K | |||
Beta | 0.88 | |||
Market Capitalization | 12.57 B | |||
Total Asset | 1.57 B | |||
Retained Earnings | 110.47 M | |||
Working Capital | 1.12 B | |||
Net Asset | 1.57 B |
About Shockwave Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shockwave Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shockwave Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shockwave Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Shockwave Stock
If you are still planning to invest in Shockwave Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Shockwave Medical's history and understand the potential risks before investing.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
CEOs Directory Screen CEOs from public companies around the world |